psychedelics investing GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer
psychedelics investing GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences
pharmaceutical investing Greenstar Biosciences Signs Agreement to Acquire 100 Percent of Eleusian Biosciences Corp.
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
VanadiumCorp Completes Rock Chip Sampling Program at its Lac Doré Vanadium-Iron-Titanium Project; 53 Samples Submitted to AGAT Laboratories for Analysis
QIMC Launches 78-Kilometre 2D Seismic Campaign Across Quebec and Nova Scotia Natural Hydrogen Districts
